Crossmark

Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy

Crossref DOI link: https://doi.org/10.1038/s41416-020-01049-3

Published Online: 2020-09-14

Published Print: 2020-11-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stelwagen, Johannes

Lubberts, Sjoukje

Steggink, Lars C. https://orcid.org/0000-0001-8955-8702
Steursma, Gerrie

Kruyt, Lara M.

Donkerbroek, Jan Willem

van Roon, Arie M.

van Gessel, Anne I.

van de Zande, Saskia C.

Meijer, Coby

Gräfin zu Eulenburg, Christine H.

Oosting, Sjoukje F. https://orcid.org/0000-0003-2754-6997
Nuver, Janine

Walenkamp, Annemiek M. E.

Jan de Jong, Igle

Lefrandt, Joop D.

Gietema, Jourik A. https://orcid.org/0000-0003-0629-7354
Funding

Funding for this research was provided by:

KWF Kankerbestrijding (RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267, RUG2011-5267)
License Information

Text and Data Mining valid from 2020-09-14

Version of Record valid from 2020-09-14
More Information

Article History

Received: 4 May 2020

Revised: 23 July 2020

Accepted: 18 August 2020

First Online: 14 September 2020

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee at the University Medical Centre Groningen (METc 2015/197). Written informed consent was obtained for all participants. The study was performed in accordance with the Declaration of Helsinki.

: The datasets generated and/or analysed during the current study

: J.A.G. received grants from Abbvie, Roche and Siemens, paid to the institution. All other authors declare no competing interests.

: This work was supported by the Dutch Cancer Society, Grant no. RUG2011-5267.

Document is current

Any future updates will be listed below